Years of life lost due to malignant neoplasms characterized by the highest mortality rate

Archives of Medical Science

Volumn 10, Issue 5, 2014, Pages 999-1006

  Pikala, Malgorzata ^a   Maniecka Bryla, Irena ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Malignant neoplasms; The Lodz province; Trends; Years of life lost

Indexed keywords

ANALYTIC METHOD; ANUS CANCER; ARTICLE; BREAST CANCER; BRONCHUS TUMOR; CANCER MORTALITY; CAUSE OF DEATH; DATA BASE; DEATH CERTIFICATE; HUMAN; LARGE INTESTINE CANCER; LUNG TUMOR; MALIGNANT NEOPLASTIC DISEASE; ONCOLOGICAL PARAMETERS; OVARY CANCER; PANCREAS CANCER; POLAND; PREMATURE MORTALITY; PROSTATE CANCER; RECTUM CANCER; STOMACH CANCER; SYSTEMATIC REVIEW; TRACHEA TUMOR; UTERINE CERVIX CANCER; YEARS OF LIFE LOST;

EID: 84908394248     PISSN: 17341922     EISSN: 18969151     Source Type: Journal    
DOI: 10.5114/aoms.2013.36237     Document Type: Article

References (28)

1. Central Statistical Office. Local Data Bank. http://www.stat.gov.pl/bdl. Accessed February 2013.
2. Ogólna charakterystyka województwa. Available at: http://www.wios.lodz.pl/docs/r10-i-wojewodztwo.pdf. Accessed February 2013.
3. Murray CJL, Lopez A. Globalne obciążenie chorobami [Polish]. Uniwersyteckie Wydawnictwo Medyczne "Vesalius", Warszawa 2000.
4. Life tables for WHO Member States. Available from: http://www.who.int/healthinfo/statistics/mortality-life-tables/en/index.html. Accessed September 2012.
5. Health statistics - Atlas on mortality in the European Union. Office for Official Publications of the European Communities, Luxembourg 2009.
6. Eurostat statistics. Available from: http://epp.eurostat.ec.europa.eu/portal/page/portal/statistics/search-database. Accessed September 2012.
7. Wojtyniak B, Goryński P. Sytuacja zdrowotna ludnos̈ci Polski [Polish]. Państwowy Zakład Higieny, Warszawa 2008.
8. Godlewski D, Wojtys̈ P, Antczak A. Predictions of cancer incidence in Wielkopolska in 2018. Contemp Oncol 2012; 16: 38-43.
9. Maniecka-Bryla I. Zmiany w stanie zdrowia mieszkańców Łodzi w okresie transformacji społeczno-ekonomicznej (na przykładzie ludnos̈ci w wieku 65-74 lata) [Polish]. Rozprawa habilitacyjna. Uniwersytet Medyczny w Łodzi 2006.
10. Marshall RJ. Standard expected years of life lost as a measure of disease burden: an investigation of its presentation, meaning and interpretation. In: Handbook of disease burdens and quality of life measures. Preedy VR, Watson RR (eds.). Springer, Berlin 2009; 3421-34.
11. Marshal RJ. Standard expected years of life lost as a measure of mortality: norms and reference to New Zealand data. Aust N Z J Public Health 2004; 28: 452-7.
12. Kim HJ, Fay MP, Feuer EJ, Mithune DN. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med 2000; 19: 335-51.
13. Tyczyński JE, Bray F, Aareleid T. Lung cancer mortality patterns in selected Central, Eastern and Southern European countries. Int J Cancer 2004; 109: 598-610.
14. Bray F, Tyczyński JE, Parkin DM. Going up or coming down? The changing phases of the lung cancer epidemic from 1967 to 1999 in the 15 European Union countries. Eur J Cancer 2004; 40: 96-125.
15. Didkowska J, Mańczuk M, McNeill A, et al. Lung cancer mortality at ages 35-54 in the European Union: ecological study of evolving tobacco epidemics. BMJ 2005; 331: 189-91.
16. Levi F, Lucchini F, Negri E, Boyle P, La Vecchia C. Mortality from major cancer sites in the European Union, 1955-1998. Ann Oncol 2003; 14: 490-5.
17. Levi F, Lucchini F, Negri E, La Vecchia C. Trends in mortality from major cancers in the European Union, including acceding countries, in 2004. Cancer 2004; 101: 2843-50.
18. Didkowska J, Wojciechowska U, Tarkowski W, et al. No-wotwory złoéliwe w Polsce w 2007 roku [Polish]. Centrum Onkologii - Instytut im. Marii Skłodowskiej-Curie, Warsaw 2009.
19. Malvezzi M, Bertuccio P, Levi F, La Vecchia C, Negri E. European cancer mortality predictions for the year 2012. Ann Oncol 2012; 23: 1044-52.
20. Didkowska J, Wojciechowska U, Zatoński W. Prognozy zachorowalnos̈ci i umieralnos̈ci na wybrane nowotwory złos̈liwe w Polsce do 2020 roku [Polish]. Centrum Onkologii - Instytut im. Marii Skłodowskiej-Curie, Warszawa 2009.
21. Bosetti C, Levi F, Rosato V, et al. Recent trends in colorectal cancer mortality in Europe. Int J Cancer 2011; 129: 180-91.
22. Klimczak A, Kempińska-Miroslawska B, Mik M. Dziki L., Dziki A. Incidence of colorectal cancer in Poland in 1999-2008. Arch Med Sci 2011; 7: 673-8.
23. Zatoński W, Didkowska J, Wojciechowska U. Epidemiologia chorób nowotworowych w Europie ͆rodkowej i Wschod-niej w porównaniu z EuropĄ ZachodniĄ i PolskĄ [Polish]. Pol Przegl Chir 2009; 81: 808-37.
24. Bosetti C, Bertuccio P, Levi F, Lucchini F, Negri E, La Vec-chia C. Cancer mortality in the European Union, 1970-2003, with a joinpoint analysis. Ann Oncol 2008; 19: 631-40.
25. Arbyn M, Raifu AO, Weiderpass E, Bray F, Anttila A. Trends of cervical cancer mortality in the member states of the European Union. Eur J Cancer 2009; 45: 2640-8.
26. Arbyn M, Antoine J, Mägi M, et al. Trends in cervical cancer incidence and mortality in the Baltic countries, Bulgaria and Romania. Int J Cancer 2011; 128: 1899-907.
27. Didkowska J, Wojciechowska U, Zatoński W. Nowotwory szyjki macicy w Polsce - epidemiologiczny bilans otwarcia i perspektywy [Polish]. Ginekol Pol 2006; 77: 660-6.
28. Kozlowska E, Szewczyk MT, Banaszkiewicz Z, Jawień A, Cierzniakowska K, Jarmocik P. Knowledge of symptoms and diagnostic possibilities of cancer diseases. Arch Med Sci 2011; 7: 304-9.